Evidence map›Paper›PMID 17341663›Full record

ArticleBlood2007

Roles of RabGEF1/Rabex-5 domains in regulating Fc epsilon RI surface expression and Fc epsilon RI-dependent responses in mast cells.

Janet Kalesnikoff, Eon J Rios, Ching-Cheng Chen, M Alejandro Barbieri, Mindy Tsai, See-Ying Tam, Stephen J Galli

Open access · greenAbstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN production.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Immunoglobulin E receptor signaling and asthma.The Journal of biological chemistry · 2011
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Janet KalesnikoffDepartment of Pathology, Stanford University School of Medicine, Stanford, CA 94305-5324, USA.
Eon J Rios
Ching-Cheng Chen
M Alejandro Barbieri
Mindy Tsai
See-Ying Tam
Stephen J Galli
Stanford University · USFlorida International University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Theaflavins and Gallic Acid in TeaS06GM008205 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI BIGGER, CHARLES H · 1989 to 2008
$17.6M
SCOR in Cellular and Molecular Mechanisms of AsthmaP50HL067674 · NHLBI · STANFORD UNIVERSITY · PI VAN DE RIJN, JAN MATT · 2002 to 2005
$4.8M
Role of Mast Cells in Inflammation and ImmunityR01CA072074 · NCI · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1996 to 2010
$4.4M
Expression and Modulation of Mast Cell Function in AsthmaR01AI070813 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2006 to 2010
$2.5M
Regulation of Mast Cell Development and FunctionR01AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 1986 to 2010
$2.4M
REGULATION OF MAST CELL DEVELOPMENT &FUNCTIONR37AI023990 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN J · 1996 to 2005
$2.2M
SCOR in Cellular and Molecular Mechanisms of AsthmaP01HL067674 · NHLBI · STANFORD UNIVERSITY · PI GALLI, STEPHEN J · 2001 to 2001
$1.2M
NCI NIH HHS CA72074NCI NIH HHS R01 CA072074NHLBI NIH HHS HL67674NHLBI NIH HHS P01 HL067674NHLBI NIH HHS P50 HL067674NIAID NIH HHS AI070813NIAID NIH HHS AI23990NIAID NIH HHS R01 AI023990NIAID NIH HHS R01 AI070813NIAID NIH HHS R37 AI023990NIGMS NIH HHS GM08205NIGMS NIH HHS S06 GM008205NIGMS NIH HHS T32 GM007365
6 · The paper itself

Abstract

RabGEF1/Rabex-5, a guanine nucleotide exchange factor (GEF) for the endocytic pathway regulator, Rab5, contains a Vps9 domain, an A20-like zinc finger (ZnF) domain, and a coiled coil domain. To investigate the importance of these domains in regulating receptor internalization and cell activation, we lentivirally delivered RabGEF1 mutants into RabGEF1-deficient (-/-) mast cells and examined Fc epsilon RI-dependent responses. Wild-type RabGEF1 expression corrected phenotypic abnormalities in -/- mast cells, including decreased basal Fc epsilon RI expression, slowed Fc epsilon RI internalization, elevated IgE + Ag-induced degranulation and IL-6 production, and the decreased ability of -/- cytosol to support endosome fusion. We showed that RabGEF1's ZnF domain has ubiquitin ligase activity. Moreover, the coiled coil domain of RabGEF1 is required for Rabaptin-5 binding and for maintaining basal levels of Rabaptin-5 and surface Fc epsilon RI. However, mutants lacking either of these domains normalized phenotypic abnormalities in IgE + antigen-activated -/- mast cells. By contrast, correction of these -/- phenotypes required a functional Vps9 domain. Thus, Fc epsilon RI-mediated mast cell functional activation is dependent on RabGEF1's GEF activity.

Indexed as

Gene Expression RegulationBone Marrow CellsCell DegranulationCells, CulturedEndocytosisGuanine Nucleotide Exchange FactorsHumansInterleukin-6Mast CellsReceptors, IgEGuanine Nucleotide Exchange FactorsInterleukin-6RABGEF1 protein, humanReceptors, IgE

Identifiers

PMID17341663
PMCPMC1890836
OpenAlexW2082580174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.